Citius Pharmaceuticals Inc (CTXR)

[Edward]

CTXR is a long term investment. What happens in day to day trading is for traders only. CTXR at their stage (late stage bio tech) has a low capital structure ( with a smaller float) that indicates good management.They are in late stages of a phase 3 clinical trial, that has shown good results thus far. Recent news with stem cells (awaiting answer from the FDA, which should come shortly) shows good vision . CTXR appears to be an excellent investment for the long term. Good management,and low capital structure (ability to raise funds if needed) and no debt.The company has a management team of greatly experienced bio pharma executives and they have purchased many shares of the company shares.